| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.7M | -40.1% |
| Cost of Revenue | $2.8M | -18.4% |
| R&D Expense | $33.6M | -65.9% |
| SG&A Expense | $22.2M | -31.5% |
| Operating Income | -$141.9M | -45.8% |
| Pre-tax Income | -$132.1M | -48.6% |
| Income Tax | -$367K | +0.0% |
| Net Income | -$132.1M | -49.3% |
| EPS (Basic) | -$1.71 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.6M | -38.4% |
| Accounts Receivable | $318K | +6.7% |
| Current Assets | $126.0M | -2.3% |
| Total Assets | $220.3M | +11.6% |
| Current Liabilities | $31.6M | +2.1% |
| Total Liabilities | $64.8M | +61.0% |
| Stockholders' Equity | $155.6M | -1.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.1M | +74.4% |
| Capital Expenditures | $121K | -90.8% |
| Investing Cash Flow | -$69.8M | -250.9% |
| Financing Cash Flow | $74.5M | +179.1% |
| Free Cash Flow | -$20.2M | +74.6% |
| -34.6% |
| EPS (Diluted) | -$1.71 | -34.6% |